Table Of Contents
1 Introduction 16
1.1 Objectives Of The Study 16
1.2 Market Definition 16
1.3 Overview Of Global Pdx Models Market 16
1.4 Currency And Pricing 17
1.5 Limitation 17
1.6 Markets Covered 17
2 Market Segmentation 19
2.1 Markets Covered 19
2.2 Geographic Scope 20
2.3 Years Considered For The Study 20
2.4 Currency And Pricing 21
2.5 Research Methodology 22
2.6 Primary Interviews With Key Opinion Leaders 25
2.7 Secondary Sources 26
2.8 Assumptions 26
3 Market Overview 27
3.1 Drivers 29
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 29
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 31
3.1.3 Rising Need For Personalized Medicine 32
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 32
3.2 Restraints 33
3.2.1 High Cost Of Pdx Models 33
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 33
3.3 Opprtunities 34
3.3.1 Increasing Demand For Humanized Pdx Models 34
3.4 Challenges 35
3.4.1 Limitations Of Pdx Models 35
4 Executive Summary 36
5 Premium Insights 39
?
6 Global Pdx Models Market, By Type 42
6.1 Overview 43
6.2 Mice Models 45
6.3 Rat Models 46
7 Global Pdx Models Market, By Tumor Type 47
7.1 Overview 48
7.2 Gastrointestinal Tumor Models 50
7.3 Gynecological Tumor Models 51
7.4 Respiratory Tumor Models 52
7.5 Urological Tumor Models 53
7.6 Hematological Tumor Models 54
7.7 Others 55
8 Global Pdx Models Market, By Application 56
8.1 Overview 57
8.2 Preclinical Drug Development And Oncology Research 59
8.3 Biomarker Analysis 60
9 Global Pdx Models Market, By End User 61
9.1 Overview 62
9.2 Contract Research Organizations 64
9.3 Pharmaceutical And Biotechnology Companies 65
9.4 Academic And Research Institutions 66
10 Global Pdx Models Market, By Geography 67
10.1 Overview 68
10.2 North America 75
10.2.1 U.S. 83
10.2.2 Canada 85
10.2.3 Mexico 87
10.3 Europe 89
10.3.1 Germany 97
10.3.2 France 99
10.3.3 U.K. 101
10.3.4 Italy 103
10.3.5 Spain 105
10.3.6 Switzerland 107
10.3.7 Netherlands 109
10.3.8 Turkey 111
10.3.9 Belgium 113
10.3.10 Russia 115
10.3.11 Rest Of Europe 117
10.4 Asia Pacific 118
10.4.1 Japan 126
10.4.2 China 128
10.4.3 India 130
10.4.4 South Korea 132
10.4.5 Australia 134
10.4.6 Singapore 136
10.4.7 Thailand 138
10.4.8 Malaysia 140
10.4.9 Indonesia 143
10.4.10 Philippines 145
10.4.11 Rest Of Asia Pacific 147
10.5 South America 148
10.5.1 Brazil 156
10.5.2 Rest Of South America 158
10.6 Middle East And Africa 159
10.6.1 South Africa 167
10.6.2 Rest Of Middle East And Africa 169
11 Global Pdx Models Market, Company Landscape 170
11.1 Company Share Analysis; Global 170
11.2 Company Share Analysis; North America 171
11.3 Company Share Analysis; Europe 172
11.4 Company Share Analysis; Asia Pacific 173
12 Company Profiles 174
12.1 Charles River 174
12.1.1 Company Overview 174
12.1.2 Revenue Analysis 174
12.1.3 Company Share Analysis 175
12.1.4 Product Portfolio 175
12.1.5 Recent Developments 175
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 176
12.2.1 Company Overview 176
12.2.2 Geographic Presence 176
12.2.3 Company Share Analysis 177
12.2.4 Product Portfolio 177
12.2.5 Recent Developments 178
12.3 Champion Oncology, Inc 179
12.3.1 Company Overview 179
12.3.2 Revenue Analysis 179
12.3.3 Company Share Analysis 180
12.3.4 Product Portfolio 180
12.3.5 Recent Developments 180
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 181
12.4.1 Company Overview 181
12.4.2 Product Portfolio 181
12.4.3 Recent Developments 181
12.5 Creative Animodel 182
12.5.1 Company Overview 182
12.5.2 Product Portfolio 182
12.5.3 Recent Developments 182
12.6 Epo Berlin-Buch Gmbh 183
12.6.1 Company Overview 183
12.6.2 Product Portfolio 183
12.6.3 Recent Developments 183
12.7 Europdx 184
12.7.1 Company Overview 184
12.7.2 Geographical Presence 184
12.7.3 Product Portfolio 185
12.7.4 Recent Developments 185
12.8 Hera Biolabs 186
12.8.1 Company Overview 186
12.8.2 Product Portfolio 186
12.8.3 Recent Developments 186
12.9 Horizon Discovery Group Plc 187
12.9.1 Company Overview 187
12.9.2 Revenue Analysis 187
12.9.3 Product Portfolio 188
12.9.4 Recent Developments 188
12.10 Mi Bioresearch Inc 189
12.10.1 Company Overview 189
12.10.2 Product Portfolio 189
12.10.3 Recent Developments 189
?
12.11 Oncodesign 190
12.11.1 Company Overview 190
12.11.2 Revenue Analysis 190
12.11.3 Product Portfolio 191
12.11.4 Recent Developments 191
12.12 Pharmatest Services Ltd 192
12.12.1 Company Overview 192
12.12.2 Geographic Presence 192
12.12.3 Product Portfolio 193
12.12.4 Recent Developments 193
12.13 The Jackson Laboratory 194
12.13.1 Company Overview 194
12.13.2 Revenue Analysis 194
12.13.3 Product Portfolio 195
12.13.4 Recent Developments 195
12.14 Urolead 196
12.14.1 Company Overview 196
12.14.2 Product Portfolio 196
12.14.3 Recent Developments 196
12.15 Wuxi Apptec 197
12.15.1 Company Overview 197
12.15.2 Geographic Presence 197
12.15.3 Product Portfolio 198
12.15.4 Recent Developments 198
12.16 Xentech 199
12.16.1 Company Overview 199
12.16.2 Product Portfolio 199
12.16.3 Recent Developments 199
13 Related Reports 200
?